US Announced Advanced Trials on COVID-19 Antibody Treatment

Two new trials soon will be underway in the United States to investigate antibody treatment approaches for Covid-19 patients. The National Institutes of Health announced on Tuesday that it is launching two advanced trials to test monoclonal antibodies in patients with Covid-19, one for patients with mild disease and another for patients who are hospitalized.

Monoclonal antibodies are immune system proteins that specifically home in on a single target. In coronavirus, they are targeted to a single structure on the body of the virus. The hope is to slow or even prevent infection.

“Studying the impact of this investigational therapeutic on multiple patient populations at the same time is critical to determining whether it can help Covid-19 patients with differing levels of disease severity,” Dr. Anthony Fauci, the nation’s top infectious disease expert and director of the National Institute of Allergy and Infectious Diseases Director, said in the announcement.

Read the source article at cnn.com

    Leave a Review or Comment

    Your email address will not be published. Required fields are marked *

    Back to top button